95 results
Equianalgesic Opioid Dosing 

#Pharmacology #Pain #Opioid #Opiate #Conversion #Equianalgesic #Table
Opioid Dosing #Pharmacology ... #Pain #Opioid #Opiate ... #Conversion #Equianalgesic
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
Review Elagolix ... the FDA for the treatment ... #Pharmacology #Elagolix ... #Orilissa #Review ... #Overview
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Management #Pain #Pharmacology ... #Opioid #Opiate ... Equianalgesics #Conversion
Transdermal Fentanyl Conversion Table

FDA’s recommendations for the total daily opiate dose required to begin or convert
Transdermal Fentanyl Conversion ... the total daily opiate ... Transdermal #Fentanyl #Conversion ... #Table #Pharmacology
Table A is a standard conversion of equianalgesic opioids. Many practice sites or text books may
is a standard conversion ... #Pharmacology #Pain ... #Opiate #Opioid ... #Conversion #Table
Alprazolam - short-acting benzodiazepine (GABA Receptor Modulator) used in the treatment of anxiety disorders. FDA approved
Modulator) used in the treatment ... #Pharmacology #Alprazolam ... #Xanax #Overview ... #Review
Opioid equivalencies - Morphine, Oxycodone, Hydromorphone - Simplified Conversion Table
Morphine 30 PO = 10 IV =
Hydromorphone - Simplified Conversion ... BrighamChiefs #Opioid #opiate ... equivalencies #equivalent #conversion ... #pharmacology #
Metformin - oral antihyperglycemic agent for treatement of type II diabetes. 8th most prescribed drug in
antihyperglycemic agent for treatement ... #Pharmacology #Metformin ... Fortamet #AMPK #Overview ... #Review
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
unique dosing conversions ... #Pharmacology #Pain ... #Opiate #Opioid ... #Conversion #Table
#Pharmacology #Phenytoin #Dilantin #Overview #Review
#Pharmacology #Phenytoin ... #Dilantin #Overview ... #Review